SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GESSI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.264
EU - Europa 7.034
AS - Asia 4.526
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
AF - Africa 4
Totale 30.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.199
IT - Italia 2.259
CN - Cina 2.234
UA - Ucraina 1.408
DE - Germania 1.294
SG - Singapore 1.071
TR - Turchia 1.007
GB - Regno Unito 570
SE - Svezia 441
FI - Finlandia 402
PL - Polonia 174
RU - Federazione Russa 150
FR - Francia 122
HK - Hong Kong 73
ID - Indonesia 64
CA - Canada 60
BE - Belgio 57
NL - Olanda 39
LT - Lituania 32
CZ - Repubblica Ceca 27
ES - Italia 22
VN - Vietnam 15
IN - India 13
IR - Iran 13
JP - Giappone 8
AU - Australia 7
EU - Europa 7
CL - Cile 6
AT - Austria 5
KR - Corea 5
MX - Messico 5
RO - Romania 5
BR - Brasile 4
CH - Svizzera 4
TW - Taiwan 4
AR - Argentina 3
DZ - Algeria 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
IQ - Iraq 3
MY - Malesia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BG - Bulgaria 2
GR - Grecia 2
IE - Irlanda 2
IM - Isola di Man 2
NO - Norvegia 2
PH - Filippine 2
SA - Arabia Saudita 2
SI - Slovenia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TH - Thailandia 1
Totale 30.861
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.407
Fairfield 2.035
Jacksonville 1.584
Chandler 1.580
Houston 1.466
Ann Arbor 1.187
Ashburn 1.065
Santa Clara 1.054
Wilmington 861
Singapore 859
Seattle 820
Cambridge 670
Izmir 516
Nanjing 489
Beijing 399
Princeton 361
Milan 309
Boardman 293
Ferrara 285
Shanghai 184
San Diego 172
Nanchang 165
Warsaw 154
Shenyang 151
Dearborn 149
Los Angeles 125
Addison 111
Bremen 104
Hebei 98
Tianjin 95
Helsinki 94
Changsha 93
New York 93
Rome 74
Hong Kong 72
Jiaxing 72
Jakarta 63
San Mateo 60
Jinan 58
London 56
Brussels 55
Norwalk 55
Florence 52
Mountain View 51
Zhengzhou 47
Kunming 46
Falls Church 43
Orange 36
Auburn Hills 35
Düsseldorf 35
Redwood City 35
Toronto 35
Bologna 32
Frankfurt am Main 32
Guangzhou 31
Ningbo 31
Munich 28
Chicago 24
Philadelphia 24
Washington 24
Verona 23
Des Moines 21
Lanzhou 20
Naples 20
Napoli 19
Taizhou 19
Tappahannock 19
Torino 18
Catania 17
Falkenstein 17
Indiana 17
Hefei 16
Brno 15
Camerino 15
Hangzhou 15
Bari 14
Dong Ket 14
Ottawa 14
Padova 13
Ferrara di Monte Baldo 12
Haikou 12
Redmond 12
Augusta 11
Kilburn 11
Livorno 11
Nice 10
Cagliari 9
Caserta 9
Meppel 9
Olomouc 9
Otura 9
Reggio Emilia 9
Turin 8
Bergamo 7
Perugia 7
Reggio Nell'emilia 7
Trieste 7
Ardabil 6
Aversa 6
Foggia 6
Totale 21.747
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.184
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 351
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 204
A glance at adenosine receptors: Novel target for antitumor therapy 202
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 201
Pharmacology of Adenosine Receptors: The State of the Art 169
The A3 adenosine receptor: history and perspectives 167
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 166
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 162
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 160
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 158
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 157
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 155
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 153
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 153
Adenosine receptors and human melanoma 147
Pathological overproduction: the bad side of adenosine 146
Adenosine receptor targeting in health and disease 145
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 141
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 141
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 140
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 139
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 138
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 138
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 137
Therapeutic potential of adenosine receptor antagonists and agonists 135
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 134
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 133
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 132
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 131
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 131
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 131
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 130
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 129
Adenosine receptors and cancer 129
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 129
Binding thermodynamics at A1 and A2A adenosine receptors 128
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 128
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 127
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 126
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 125
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 125
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 125
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 124
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 123
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 123
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 123
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 123
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 122
New potent and selective human adenosine A3 receptor antagonists. 122
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 121
Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents 121
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 120
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 119
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 119
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 119
Adenosine and lymphocyte regulation 119
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 118
A(2A) adenosine receptors in human peripheral blood cells 118
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 118
null 118
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 118
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 117
Agonists and antagonists: Molecular mechanisms and therapeutic applications 117
The A3 adenosine receptor: an enigmatic player in cell biology. 116
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 116
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 116
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 115
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 115
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 114
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 114
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 114
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 114
null 113
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 113
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 113
Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands 112
null 112
Adenosine receptors in health and disease 112
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 111
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 110
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 110
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 110
Binding thermodynamics of 5-HT(1A) receptor ligands 110
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 110
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 110
Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors 109
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 109
van't Hoff Based Thermodynamics 109
Adenosine A2A receptors in human circulating blood elements 108
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 108
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 108
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 108
The P2X7 receptor as a therapeutic target. 107
Synthesis, molecular modeling and opioid receptor affinity of 9,10-diazatricyclo[4.2.1.1 2,5]decanes and 2,7-diazatricyclo[4.4.0.0 3,8]decanes structurally related to 3,8-diazabicyclo[3.2.1]octanes 107
null 107
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 107
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells 106
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 106
null 106
Totale 13.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.449
Totale 146.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.470 0 0 0 0 0 0 484 550 414 647 281 94
2020/20214.151 397 431 173 487 220 445 145 471 76 563 511 232
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/20253.105 188 220 612 424 973 666 22 0 0 0 0 0
Totale 31.254